…ized in part by hyperfibrinolysis. Inhibiting fibrinolysis with tranexamic acid (TXA) decreases mortality in trauma patients, with greater benefit th…
TXA
This drug is selected. Its supporting articles are shown below.
Articles mentioning TXA
7 articles · page 1 of 1…roportions to receive either placebo or one of four intravenous TXA doses: 300 mg, 500 mg, 1000 mg or 3000 mg. Dose selection and s…
… raised to NHS England’s National Patient Safety Team regarding tranexamic acid use in gastrointestinal bleeding, and in light of the 2020 publ…
…d to be lower than those in the DRC.Conclusions Availability of oxytocin, misoprostol, heat-stable carbetocin and TXA was suboptimal and…
…OR ‘meningeal artery’) AND (Avastin OR Bevacizumab OR ‘TXA’ OR ‘Tranexamic Acid’ OR ‘medication adjunct’) AND (embolization). These criteria we…
…Tranexamic acid (TXA) is an antifibrinolytic agent which inhibits the activatio…
…afety of both combined intravenous and topical tranexamic acid (TXA) therapy, or topical administration alone, assessing its effect…